| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Mr. Poliang Yeh CEO | TWSE Exchange | TW0001470003 ISIN |
| TW Country | - Employees | - Last Dividend | 29 Jun 2000 Last Split | 10 Dec 2009 IPO Date |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is a leading company focused on the research, development, manufacture, and sales of active pharmaceutical ingredients (APIs) primarily in Taiwan and the United States. The company has a rich history since its establishment in 1964, originally known as China Chemical Synthesis Industry Co., Ltd. Headquartered in New Taipei City, Taiwan, it has made significant strides in the pharmaceutical industry by providing a wide range of API products and bulk pharmaceuticals. Additionally, Chunghwa Chemical Synthesis & Biotech offers comprehensive research and development, and contract manufacturing services, catering to the needs of new drug developers and generic drug companies alike.
Chunghwa Chemical Synthesis & Biotech specializes in an extensive range of API products. These include immunosuppressants for preventing organ transplant rejection, oncology drugs for cancer treatment, antivirals for viral infections, and immunomodulating agents that modify the immune system. Additionally, the company manufactures peptide drugs that represent a significant advancement in pharmaceuticals.
The company's portfolio includes a versatile range of bulk pharmaceutical products. This encompasses anti-anxiety agents for anxiety disorders, antidiabetics for diabetes management, laxatives for treating constipation, antifungals for fungal infections, antihistamines for allergy relief, antiseptics for preventing infection, antiulcerants for ulcer treatment, and cardiovascular drugs for heart conditions. They also produce skeletal muscle relaxants for muscle spasms, hypolipemics for lowering lipid levels, antineoplastics for cancer treatment, antihyperlipidemias for cholesterol management, and immunosuppressants for immune system regulation.
The company invests heavily in research and development to innovate and improve pharmaceutical products. This commitment ensures that Chunghwa Chemical Synthesis & Biotech stays at the forefront of pharmaceutical advancements, offering cutting-edge solutions to the healthcare industry.
Chunghwa Chemical Synthesis & Biotech provides tailor-made contract manufacturing services, offering its expertise and facilities to both new drug developers and generic drug companies. These services extend from the initial phases of drug development through to full-scale production, reflecting the company's adaptability and capacity to meet a diverse range of client needs.